Kyrgyzstan to complete second stage of seroprevalence study for Covid-19 in late April

Kyrgyzstan|health|February 22, 2021 / 12:49 PM

AKIPRESS.COM - Kyrgyzstan will complete the second stage of seroprevalence study of SARS-CoV-2-specific antibodies in late April, Health Ministry's Viral Infections Control Research Center Head Zuridin Nurmatov told AKIpress on February 22...

To Read the Full Story

Republication of any material is prohibited without a written agreement with AKIpress News Agency.

Any citation must be accompanied by a hyperlink to akipress.com.

Our address:

299/5 Chingiz Aitmatov Prosp., Bishkek, the Kyrgyz Republic

e-mail: english@akipress.org, akipressenglish@gmail.com;

Log in

Forgot your password? - recover

Not registered yet? - sign-up

Sign-up

I have an account - log in

Password recovery

I have an account - log in